Metastatic malignant melanoma and Conjunctivitis

Summary:

Conjunctivitis is found among people with Metastatic malignant melanoma, especially for people who are male, 60+ old.

The study analyzes which people have Conjunctivitis with Metastatic malignant melanoma. It is created by eHealthMe based on reports of 76 people who have Metastatic malignant melanoma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Metastatic malignant melanoma?

Metastatic malignant melanoma (spreadable cancer tumour of melanine) is found to be associated with 235 drugs and 296 conditions by eHealthMe. Check the latest studies of Metastatic malignant melanoma.

What is Conjunctivitis?

Conjunctivitis (pink eye) is found to be associated with 1,298 drugs and 1,644 conditions by eHealthMe. Check the latest studies of Conjunctivitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

76 people who have Metastatic Malignant Melanoma and Conjunctivitis are studied.

Would you have Conjunctivitis when you have Metastatic malignant melanoma?

Gender of people who have Metastatic Malignant Melanoma and experienced Conjunctivitis *:

female: 28.77 %
male: 71.23 %

Age of people who have Metastatic Malignant Melanoma and experienced Conjunctivitis *:

Common co-existing conditions for these people *:

High Blood Pressure: 28 people, 36.84%
Pain: 26 people, 34.21%
Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 23 people, 30.26%
Procedural Vomiting: 23 people, 30.26%
Procedural Nausea: 23 people, 30.26%
Procedural Headache: 23 people, 30.26%
Metastases To Central Nervous System (cancer spreads to central nervous system): 23 people, 30.26%
Malignant Melanoma (skin cancer rises from melancytes): 22 people, 28.95%
Vision Blurred: 21 people, 27.63%
Constipation: 14 people, 18.42%

Common drugs taken by these people *:

Common symptoms for these people *:

Fever: 40 people, 52.63%
Weakness: 30 people, 39.47%
Cough: 29 people, 38.16%
Hyperglycemia (high blood sugar): 27 people, 35.53%
Fatigue (feeling of tiredness): 27 people, 35.53%
Photosensitivity Reaction: 26 people, 34.21%
Pain In Extremity: 25 people, 32.89%
Lymphoedema (localized fluid retention and tissue swelling): 25 people, 32.89%
Mucosal Dryness (dryness of mucous membrane): 24 people, 31.58%
Vision Blurred: 24 people, 31.58%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Conjunctivitis?

- Check whether Conjunctivitis is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Metastatic malignant melanoma (24,460 reports)
Conjunctivitis (22,439 reports)

All the drugs that are associated with Conjunctivitis:

Conjunctivitis (1,298 drugs)

All the conditions that are associated with Conjunctivitis:

Conjunctivitis (1,644 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Conjunctivitis and Metastatic malignant melanoma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.